Integrated Filing — IndAS

General information about company
Scrip Code	532162
NSE Symbol	JKPAPER
MSEI Symbol	NOTLISTED
ISIN	INE789E01012
Name of company	JK PAPER LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	19-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	12-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Paper and Packaging Products
Start date and time of board meeting	19-May-2025   13:30:00
End date and time of board meeting	19-May-2025   16:25:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-01-29
Indicate Company website link for updated RPT policy of the Company	https://jkpaper.com/wp-content/uploads/2025/01/Policy_on_Materiality_of_RPTs_and_on_dealings_with_RPTs.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	14389700000	57316400000
	Other income	163700000	986100000
	Total income	14553400000	58302500000
2	Expenses
(a)	Cost of materials consumed	7730100000	29663500000
(b)	Purchases of stock-in-trade	1984800000	8338400000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	14000000	-471800000
(d)	Employee benefit expense	1060400000	4527200000
(e)	Finance costs	424000000	1495200000
(f)	Depreciation, depletion and amortisation expense	633700000	2498700000
(f)	Other Expenses
1	Power, Fuel and Water	878000000	3573200000
2	Others	865400000	4086600000
	Total other expenses	1743400000	7659800000
	Total expenses	13590400000	53711000000
3	Total profit before exceptional items and tax	963000000	4591500000
4	Exceptional items	0	0
5	Total profit before tax	963000000	4591500000
6	Tax expense
7	Current tax	481300000	1314200000
8	Deferred tax	-259200000	-375200000
9	Total tax expenses	222100000	939000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	740900000	3652500000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	740900000	3652500000
17	Other comprehensive income net of taxes	36900000	49500000
18	Total Comprehensive Income for the period	777800000	3702000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1694000000	1694000000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		46685400000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	4.37	21.56
	Diluted earnings (loss) per share from continuing operations	4.37	21.56
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	4.37	21.56
	Diluted earnings (loss) per share from continuing and discontinued operations	4.37	21.56
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		NOTES: STANDALONE AUDITED FINANCIAL RESULTS FOR THE QUARTER & YEAR ENDED 31st MARCH,2025 n n1.tLower sales realisation due to continued high imports and increase in wood cost have impacted the performance. n n2.tThe Board of Directors of the Company at its meeting held on 13th December 2024, have approved a Composite Scheme of Arrangement under Sections 230 to 232 (read with Section 66 and other applicable provisions) of the Companies Act, 2013 between the Company (Transferee Company), its subsidiaries namely JKPL Utility Packaging Solutions Private Limited (Formerly Manipal Utility Packaging Solutions Private Limited), Securipax Packaging Private Limited, Horizon Packs Private Limited, Enviro Tech Ventures Limited (Transferor/Demerged Companies) and Resulting Company namely PSV Agro Products Private Limited and their respective shareholders (the ‘Scheme’).The aforementioned Scheme having appointed dates of 1st April 2024 and 1st April 2025, as further detailed in the Scheme, is subject to required regulatory and other necessary approvals. Pending necessary approvals, the effect of the Scheme has not been given in these Financial Results. n n3.ti) As per the terms of agreement on the acquisition of Radhesham Wellpack Private Limited (RWPL), the Company has acquired 60% of Equity Shares on 3rd February 2025. Consequently, RWPL has become a Subsidiary of the Company w.e.f. 3rd February 2025. n nii) As per the terms of agreement on the acquisition Quadragen Vethealth Private Limited (QVPL), the Company has acquired 62.14% of Equity Shares on 25th March 2025. Consequently, QVPL has become a Subsidiary of the Company w.e.f. 25th March 2025. n n4.tThe Board of Directors has recommended a Dividend of Rs. 5/- per share (50%), amounting to Rs.84.70 Crore on the Equity Share Capital for the financial year ended 31st March 2025. n n5.tThe Company had opted for the new tax regime as per Section 115BAA of the Income Tax Act, 1961 (the Act) during the previous financial year which had resulted in Deferred Tax credit of Rs.43.55 crore during the corresponding quarter and Rs.174.20 crore up to March 24, last year, hence the tax provision and Profit after Tax (PAT) are not comparable. n n6.tFigures for the previous periods have been regrouped / rearranged, wherever necessary. Figures of the last quarter ended 31st March,2025 and 31st March,2024 are the balancing figures between audited figures for the full financial year and the published year-to-date figures for the nine months ended of the relevant financial year. The Company does not have any Exceptional Item to report for the current quarter. n n7.tThe Company has only one reportable business segment namely ‘Paper and Packaging Products’. Segment reporting is given in Consolidated Financial Results. n n8.tThese Standalone Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 19th May 2025. n n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	40426600000
	Capital work-in-progress	715900000
	Investment property	0
	Goodwill	1000000
	Other intangible assets	168200000
	Intangible assets under development	71100000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	16855700000
	Trade receivables, non-current	0
	Loans, non-current	714000000
	Other non-current financial assets	416400000
	Total non-current financial assets	17986100000
	Deferred tax assets (net)	0
	Other non-current assets	470900000
	Total non-current assets	59839800000
2	Current assets
	Inventories	9778700000
	Current financial asset
	Current investments	2134900000
	Trade receivables, current	1876900000
	Cash and cash equivalents	29000000
	Bank balance other than cash and cash equivalents	81700000
	Loans, current	500000000
	Other current financial assets	242200000
	Total current financial assets	4864700000
	Current tax assets (net)	0
	Other current assets	3766000000
	Total current assets	18409400000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	78249200000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1694000000
	Other equity	46685400000
	Total equity attributable to owners of parent	48379400000
	Non controlling interest
	Total equity	48379400000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	11190600000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	1024200000
	Total non-current financial liabilities	12214800000
	Provisions, non-current	127700000
	Deferred tax liabilities (net)	5179500000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	17522000000
	Current liabilities
	Current financial liabilities
	Borrowings, current	4266900000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	109200000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	5770700000
	Total Trade payable	5879900000
	Other current financial liabilities	947700000
	Total current financial liabilities	11094500000
	Other current liabilities	889100000
	Provisions, current	107300000
	Current tax liabilities (Net)	256900000
	Deferred government grants, Current	0
	Total current liabilities	12347800000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	29869800000
	Total equity and liabilites	78249200000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	RE-MEASUREMENT GAIN / (LOSS) ON DEFINED BENEFIT PLANS	-2600000	-25300000
2	EQUITY INSTRUMENTS THROUGH OTHER COMPREHENSIVE INCOME	45300000	79800000
	Total Amount of items that will not be reclassified to profit and loss	42700000	54500000
2	Income tax relating to items that will not be reclassified to profit or loss	5800000	5000000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	36900000	49500000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			4591500000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			1495200000
	Adjustments for decrease (increase) in inventories			-1999100000
	Adjustments for decrease (increase) in trade receivables, current			-164600000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			734900000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			2498700000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-800000000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			4800000
	Adjustments for dividend income			1800000
	Adjustments for interest income			489300000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-410000000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			868800000
	Net cash flows from (used in) operations			5460300000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			1091300000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			4369000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			4745300000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			18000000
	Purchase of property, plant and equipment			1737600000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			145000000
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			1800000
	Interest received			494800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			6601600000
	Net cash flows from (used in) investing activities	488300000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			151800000
	Repayments of borrowings			3648700000
	Payments of lease liabilities			200700000
	Dividends paid			846600000
	Interest paid			818400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-5362600000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-505300000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-505300000
	Cash and cash equivalents cash flow statement at beginning of period			534300000
	Cash and cash equivalents cash flow statement at end of period			29000000